XXXX control in a large multi-ethnic cohort in Amsterdam, The Netherlands: The HELIUS study.

@entity1 @entity101
OBJECTIVE: @entity101 is a major problem among European ethnic minority groups. We assessed the current situation of @entity101 prevalence and its management among a multi-ethnic population in Amsterdam, The Netherlands. METHODS: Data from the HELIUS study were used including 12,974 @entity1 (1871 Ghanaian, 2184 African Surinamese, 2278 South-Asian Surinamese, 2277 Turkish, 2222 Moroccan and 2142 Dutch origin @entity1 ), aged 18-70years. Comparisons among groups were made using proportions and age-adjusted prevalence ratios (PRs). RESULTS: @entity101 prevalence ranged from 24% and 16% in Moroccan @entity1 and @entity1 to 52% and 62% in Ghanaian @entity1 and @entity1 . Except for Moroccan @entity1 , age-adjusted PR of @entity101 was higher in all the ethnic minority groups than in Dutch. Among @entity101 , ethnic minority groups generally had higher levels of @entity101 awareness and BP lowering treatment than Dutch. Moreover, prevalence rates for the prescription of more than one BP lowering drug were generally higher in African and South-Asian origin groups compared with Dutch origin @entity1 . By contrast, BP control levels were lower in all the ethnic groups than in Dutch, with control rates being significantly lower in Ghanaian @entity1 (26%, PR=0.49; 95% CI, 0.37-0.66) and @entity1 (45%, PR=0.64; 0.52-0.77), African-Surinamese @entity1 (30%, PR=0.61; 0.46-0.81) and @entity1 (45%, PR=0.72; 0.51-0.77), and South-Asian Surinamese @entity1 (43%, PR=0.77; 0.61-0.97) and @entity1 (47%, PR=0.76; 0.63-0.92) compared with Dutch @entity1 (53%) and @entity1 (61%). CONCLUSION: Our findings indicate poor BP control in ethnic minority groups despite the high treatment levels. More work is needed to unravel the potential factors contributing to the poor control in order to improve BP control in ethnic minority groups, particularly among African and South-Asian origin groups.
